STERIS Comprehensive Income 2010-2024 | STE
STERIS comprehensive income from 2010 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
- STERIS comprehensive income for the quarter ending September 30, 2024 was $-0.166B, a 57.12% decline year-over-year.
- STERIS comprehensive income for 2024 was $-0.329B, a 2.48% increase from 2023.
- STERIS comprehensive income for 2023 was $-0.321B, a 52.86% increase from 2022.
- STERIS comprehensive income for 2022 was $-0.21B, a 242.58% increase from 2021.
| STERIS Annual Comprehensive Income (Millions of US $) |
|
|---|---|
| 2024 | $-329 |
| 2023 | $-321 |
| 2022 | $-210 |
| 2021 | $-61 |
| 2020 | $-235 |
| 2019 | $-160 |
| 2018 | $12 |
| 2017 | $-241 |
| 2016 | $-68 |
| 2015 | $-67 |
| 2014 | $4 |
| 2013 | $-4 |
| 2012 | $14 |
| 2011 | $35 |
| 2010 | $13 |
| 2009 | $-16 |
| STERIS Quarterly Comprehensive Income (Millions of US $) |
|
|---|---|
| 2024-09-30 | $-166 |
| 2024-06-30 | $-323 |
| 2024-03-31 | $-329 |
| 2023-12-31 | $-253 |
| 2023-09-30 | $-387 |
| 2023-06-30 | $-311 |
| 2023-03-31 | $-321 |
| 2022-12-31 | $-364 |
| 2022-09-30 | $-598 |
| 2022-06-30 | $-388 |
| 2022-03-31 | $-210 |
| 2021-12-31 | $-137 |
| 2021-09-30 | $-106 |
| 2021-06-30 | $-37 |
| 2021-03-31 | $-61 |
| 2020-12-31 | $-2 |
| 2020-09-30 | $-131 |
| 2020-06-30 | $-208 |
| 2020-03-31 | $-235 |
| 2019-12-31 | $-149 |
| 2019-09-30 | $-226 |
| 2019-06-30 | $-157 |
| 2019-03-31 | $-160 |
| 2018-12-31 | $-167 |
| 2018-09-30 | $-127 |
| 2018-06-30 | $-121 |
| 2018-03-31 | $12 |
| 2017-12-31 | $-55 |
| 2017-09-30 | $-80 |
| 2017-06-30 | $-148 |
| 2017-03-31 | $-241 |
| 2016-12-31 | $-275 |
| 2016-09-30 | $-94 |
| 2016-06-30 | $-86 |
| 2016-03-31 | $-68 |
| 2015-12-31 | $-74 |
| 2015-09-30 | $-59 |
| 2015-06-30 | $-54 |
| 2015-03-31 | $-67 |
| 2014-12-31 | $-32 |
| 2014-09-30 | $-13 |
| 2014-06-30 | $9 |
| 2014-03-31 | $4 |
| 2013-12-31 | $4 |
| 2013-09-30 | $3 |
| 2013-06-30 | $-9 |
| 2013-03-31 | $-4 |
| 2012-12-31 | $10 |
| 2012-09-30 | $8 |
| 2012-06-30 | $-1 |
| 2012-03-31 | $14 |
| 2011-12-31 | $10 |
| 2011-09-30 | $20 |
| 2011-06-30 | $44 |
| 2011-03-31 | $35 |
| 2010-12-31 | $21 |
| 2010-09-30 | $21 |
| 2010-06-30 | $-0 |
| 2010-03-31 | $13 |
| 2009-12-31 | $18 |
| 2009-09-30 | $16 |
| 2009-06-30 | $8 |
| 2009-03-31 | $-16 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $20.602B | $5.139B |
| STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $201.646B | 24.60 |
| Intuitive Surgical (ISRG) | United States | $191.920B | 100.34 |
| Edwards Lifesciences (EW) | United States | $44.778B | 28.43 |
| Alcon (ALC) | Switzerland | $42.567B | 28.48 |
| IQVIA Holdings (IQV) | United States | $36.345B | 20.02 |
| IDEXX Laboratories (IDXX) | United States | $34.155B | 40.22 |
| DexCom (DXCM) | United States | $31.470B | 47.39 |
| Waters (WAT) | United States | $22.372B | 33.08 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.912B | 0.00 |
| Hologic (HOLX) | United States | $16.503B | 17.82 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.421B | 13.78 |
| Sysmex ADR (SSMXY) | Japan | $11.599B | 36.37 |
| Globus Medical (GMED) | United States | $11.495B | 29.11 |
| Penumbra (PEN) | United States | $9.232B | 90.43 |
| Masimo (MASI) | United States | $9.157B | 44.31 |
| Glaukos (GKOS) | United States | $8.418B | 0.00 |
| Teleflex (TFX) | United States | $8.366B | 13.34 |
| Integer Holdings (ITGR) | United States | $4.558B | 25.83 |
| PROCEPT BioRobotics (PRCT) | United States | $4.359B | 0.00 |
| Veracyte (VCYT) | United States | $3.174B | 95.23 |
| Inari Medical (NARI) | United States | $3.163B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.555B | 14.75 |
| Nihon Kohden (NHNKY) | Japan | $2.490B | 18.91 |
| Tandem Diabetes Care (TNDM) | United States | $2.454B | 0.00 |
| TransMedics (TMDX) | United States | $2.101B | 66.60 |
| Elekta AB (EKTAY) | Sweden | $2.085B | 18.74 |
| Integra LifeSciences Holdings (IART) | United States | $1.752B | 9.15 |
| RxSight (RXST) | United States | $1.413B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.323B | 0.00 |
| Artivion (AORT) | United States | $1.230B | 81.50 |
| Pulse Biosciences (PLSE) | United States | $1.152B | 0.00 |
| OPKO Health (OPK) | United States | $1.037B | 0.00 |
| Paragon 28 (FNA) | United States | $0.867B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.743B | 12.62 |
| Mesa Laboratories (MLAB) | United States | $0.737B | 17.36 |
| AxoGen (AXGN) | United States | $0.736B | 0.00 |
| IRadimed (IRMD) | United States | $0.697B | 37.69 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.681B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.648B | 34.13 |
| SiBone (SIBN) | United States | $0.580B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.566B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.529B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.455B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.441B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.427B | 23.10 |
| Delcath Systems (DCTH) | United States | $0.383B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.366B | 0.00 |
| NeuroPace (NPCE) | United States | $0.339B | 0.00 |
| CVRx (CVRX) | United States | $0.330B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.217B | 0.00 |
| Inogen (INGN) | United States | $0.205B | 0.00 |
| Accuray (ARAY) | United States | $0.199B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.183B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.183B | 0.00 |
| Nevro (NVRO) | United States | $0.152B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.133B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.120B | 12.88 |
| Spectral Diagnostics (EDTXF) | Canada | $0.100B | 0.00 |
| LENSAR (LNSR) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.091B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.079B | 0.00 |
| InspireMD (NSPR) | Israel | $0.075B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.072B | 0.00 |
| 908 Devices (MASS) | United States | $0.071B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.071B | 0.00 |
| Hyperfine (HYPR) | United States | $0.064B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.060B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.054B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.046B | 0.00 |
| Spectral AI (MDAI) | United States | $0.045B | 0.00 |
| Neuronetics (STIM) | United States | $0.043B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.039B | 0.00 |
| Envoy Medical (COCH) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| NexGel (NXGL) | United States | $0.033B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.028B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.025B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.012B | 0.00 | |
| T2 Biosystems (TTOO) | United States | $0.009B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Avinger (AVGR) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |